StackTerminal.Health

BETA
Research compound

This compound is primarily studied in research/clinical settings & may not be widely available as a regulated over-the-counter supplement. Information is provided for educational purposes only — not as a recommendation to use. See our Safety page.

Selank

Peptide with anxiolytic claims largely from limited/region-specific clinical literature; evidence quality varies.

constraint:not-drug-test-safeevidence:lowform:othermicro:calmmicro:sleep-calmmicro:stresspop:clinical-populationsstudy:other-unclear
Evidence last reviewed: 04 Apr 2026
Supplement note
Private note on this supplement

Save how you reacted, what dose worked, what to watch for, or anything you want to remember later in your Notes tab.

Sign in to keep a private note on Selank.
Biomarkers studied
Outcomes directly measured across the evidence records below
Cognitive
Anxiety
Evidence
2 records
Anxiety symptom measures
Patients with generalized anxiety disorder/neurasthenia (reported clinical study)Clinical-biological study (older literature)
PUBMEDLow

Clinical literature reports anxiolytic effects in patient cohorts, but study designs & reporting standards vary & limit certainty.

Dose:
Anxiolytic effect vs. phenazepam in anxiety disorders
60 patients with phobic-anxiety and somatoform disordersComparative clinical study
PUBMEDLow

Selank showed pronounced anxiolytic & mild nootropic effects compared with phenazepam; the anxiolytic effect persisted for approximately one week after the last dose. Methodology reflects older Russian clinical reporting standards, limiting generalizability.

Dose:
Forms
Lyophilized powder
Research material (vendor listing)

Stacks containing Selank

Public community stacks that include this ingredient.

Explore all stacks →
sleepcalmfocus

Non-stimulant cognitive/calm pairing commonly discussed in nootropic communities.

Selank
1mg
Semax
10mg
New
View